Volume | 0 |
|
|||||
News | - | ||||||
Day High | Low High |
||||||
Day Low |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Standard BioTools Inc | LAB | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.54 |
Trades | Volume | Avg Volume | 52 Week Range |
---|---|---|---|
0 | 0 | - | 1.46 - 3.16 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
- | 0 | $ 2.54 | USD |
Standard BioTools Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
736.9M | 290.12M | - | 106.34M | -74.66M | -0.26 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Standard BioTools News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LAB Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.82 | 2.835 | 2.48 | 2.59 | 2,849,384 | -0.28 | -9.93% |
1 Month | 2.69 | 3.04 | 2.48 | 2.72 | 3,058,169 | -0.15 | -5.58% |
3 Months | 2.40 | 3.04 | 2.1715 | 2.62 | 2,111,976 | 0.14 | 5.83% |
6 Months | 2.04 | 3.04 | 1.735 | 2.44 | 1,615,366 | 0.50 | 24.51% |
1 Year | 1.74 | 3.16 | 1.46 | 2.40 | 1,004,033 | 0.80 | 45.98% |
3 Years | 3.60 | 4.23 | 0.92 | 2.23 | 767,378 | -1.06 | -29.44% |
5 Years | 3.60 | 4.23 | 0.92 | 2.23 | 767,378 | -1.06 | -29.44% |
Standard BioTools Description
Standard BioTools Inc. develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines. Its segments include Proteomics and Genomics. Proteomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of proteins. Genomics segment includes its instruments, consumables, software, and services based upon technologies used in the identification of genes and their functions. It provides insights in health and disease using its mass cytometry and microfluidics technologies, which serve applications in proteomics and genomic. It works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories around the world, focusing on the needs in translational and clinical research, including oncology, immunology, and immunotherapy. The Company distributes its systems through its direct sales force and support organizations. |